Related Experiment Video
Updated: Mar 11, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Disparities in Hormone Replacement Therapy Prescribing for Women With Intellectual Disabilities
Charis Bontoft1, Indermeet Sawhney1, Asif Zia1
1Hertfordshire Partnership University NHS Foundation Trust (HPFT), Hatfield, UK.
Women with intellectual disabilities receive significantly less hormone replacement therapy (HRT) for menopause compared to the general population. This study highlights inequities in menopause care and calls for improved access and recognition for this underrepresented group.
Area of Science:
- Women's Health
- Health Services Research
- Intellectual Disabilities Research
Background:
- Menopause research and care significantly underrepresent individuals with intellectual disabilities.
- There is a critical need to address disparities in healthcare for women with intellectual disabilities.
Purpose of the Study:
- To evaluate the prescribing patterns of hormone replacement therapy (HRT) for women with intellectual disabilities.
- To identify barriers and facilitators to HRT access in this population.
- To recommend improvements in menopause care for women with intellectual disabilities.
Main Methods:
- A mixed-methods service evaluation was conducted in an NHS Trust.
- Phase 1 involved statistical comparison of HRT prescribing data (n=149) in women aged 40-79 with intellectual disabilities against the general population.
- Phase 2 included qualitative analysis of a psychiatrist focus group (n=6) and a GP interview (n=1).
Main Results:
- HRT prescribing was significantly lower (3.3%) in women with intellectual disabilities compared to the general population (17.2%).
- Qualitative findings revealed low clinician awareness, diagnostic overshadowing, and system-level issues as barriers.
- Psychiatrist advocacy, proactive carers, and improved care collaboration were identified as facilitators.
Conclusions:
- Women with intellectual disabilities experience substantial inequity in accessing HRT for menopause.
- Urgent recommendations are needed to enhance recognition, treatment access, and health outcomes.
- Addressing these disparities is crucial for equitable women's health.
Related Concept Videos
Intrauterine Drug Delivery Systems
Dosage Regimen: Individualization
Drug Dosing: Geriatric Patients
Intellectual Disability
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

